Another dangerous combination for hypoglycemic coma: concurrent use of sibutramine and lorazepam. (Record no. 17710084)

MARC details
000 -LEADER
fixed length control field 01241 a2200349 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515104252.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200806s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1460-2393
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1093/qjmed/hcm147
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Lin, Y-Y
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20080604
245 00 - TITLE STATEMENT
Title Another dangerous combination for hypoglycemic coma: concurrent use of sibutramine and lorazepam.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. QJM : monthly journal of the Association of Physicians
Date of publication, distribution, etc. Mar 2008
300 ## - PHYSICAL DESCRIPTION
Extent 243-5 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Anxiety Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Appetite Depressants
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclobutanes
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetic Coma
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fasting
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lorazepam
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hsu, C-W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chu, S-J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tsai, S-H
773 0# - HOST ITEM ENTRY
Title QJM : monthly journal of the Association of Physicians
Related parts vol. 101
-- no. 3
-- p. 243-5
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1093/qjmed/hcm147">https://doi.org/10.1093/qjmed/hcm147</a>
Public note Available from publisher's website

No items available.